Compile Data Set for Download or QSAR
Report error Found 379 with Last Name = 'itadani' and Initial = 's'
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104905(CHEMBL3597618)
Affinity DataIC50: 0.220nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50066948(CHEMBL3403187)
Affinity DataIC50: 0.310nMAssay Description:Antagonist activity at human CysLT2 receptor expressed in HEK293 cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubat...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104904(CHEMBL3597617)
Affinity DataIC50: 0.320nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104883(CHEMBL3597616)
Affinity DataIC50: 0.470nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50066911(CHEMBL3401689)
Affinity DataIC50: 0.490nMAssay Description:Antagonist activity at human CysLT2 receptor expressed in HEK293 cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubat...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104872(CHEMBL3597535)
Affinity DataIC50: 0.560nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50066947(CHEMBL3403186)
Affinity DataIC50: 0.590nMAssay Description:Antagonist activity at human CysLT1 receptor expressed in CHO cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubated ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50033089(CHEMBL3342959)
Affinity DataIC50: 0.620nMAssay Description:Antagonist activity at human CysLT2 receptor expressed in HEK293 cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubat...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104864(CHEMBL3597527)
Affinity DataIC50: 0.620nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50066911(CHEMBL3401689)
Affinity DataIC50: 0.790nMAssay Description:Antagonist activity at human CysLT1 receptor expressed in CHO cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubated ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104910(CHEMBL3597623)
Affinity DataIC50: 0.790nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104869(CHEMBL3597532)
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50033094(CHEMBL3342964)
Affinity DataIC50: 0.870nMAssay Description:Antagonist activity at human CysLT2 receptor expressed in HEK293 cells assessed as inhibition of LTD4-inudced intracellular calcium influx preincubat...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50104905(CHEMBL3597618)
Affinity DataIC50: 0.880nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50104883(CHEMBL3597616)
Affinity DataIC50: 0.890nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249315(US9463192, 7 | US9763943, 7 | US9993479, 7 | US103...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249316(US9463192, 8-1 | US9763943, 8-1 | US9993479, 8-1 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249318(US9463192, 8-4 | US9763943, 8-4 | US9993479, 8-4 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249320(US9463192, 9-2 | US9763943, 9-2 | US9993479, 9-2 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249321(US9463192, 11 | US9763943, 11 | US9993479, 11 | US...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249323(US9463192, 14-5 | US9763943, 14-5 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249324(US9463192, 14-6 | US9763943, 14-6 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249325(US9463192, 15-4 | US9763943, 15-4 | US9993479, 15-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249334(US9463192, 15-87 | US9763943, 15-87 | US9993479, 1...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249339(US9463192, 21-1 | US9763943, 21-1 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249340(US9463192, 21-2 | US9763943, 21-2 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM340800(US9763943, 21-9)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249342(US9463192, 21-13 | US9763943, 21-13 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249343(US9463192, 21-37 | US9763943, 21-37 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249344(US9463192, 21-51 | US9763943, 21-51 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 379 total ) | Next | Last >>
Jump to: